Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The v-erbA oncogene (review).

D Thormeyer1, A Baniahmad

  • 1Genetic Institute, Justus-Liebig-University, D-35392 Giessen, Germany.

International Journal of Molecular Medicine
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical polycystic ovary syndrome--a genetic analysis.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2014
Same author

Targeting heat shock proteins in prostate cancer.

Current medicinal chemistry·2013
Same author

Sirtuin family: a link to metabolic signaling and senescence.

Current medicinal chemistry·2010
Same author

Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.

Oncogene·2008
Same author

BKCa channels activating at resting potential without calcium in LNCaP prostate cancer cells.

The Journal of membrane biology·2006
Same author

Co-activator and co-repressor interplay on the human androgen receptor.

Andrologia·2005
Same journal

Exercise and fluoxetine in Alzheimer's disease: Molecular mechanisms of synergistic and antagonistic effects (Review).

International journal of molecular medicine·2026
Same journal

[Corrigendum] Arginine ADP‑ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.

International journal of molecular medicine·2026
Same journal

Oral‑gut axis in systemic disease: A barrier‑metabolism‑immunity three‑dimensional regulatory model (Review).

International journal of molecular medicine·2026
Same journal

Endothelial dysfunction: A central mechanism linking autosomal dominant polycystic kidney disease and intracranial aneurysms (Review).

International journal of molecular medicine·2026
Same journal

ABCG2 transporter: Structural and functional associations with gout (Review).

International journal of molecular medicine·2026
Same journal

Research progress on the chemical and pharmacological effects of <i>Semen Strychni</i> (Review).

International journal of molecular medicine·2026
See all related articles

The v-erbA oncoprotein, a nuclear hormone receptor, drives neoplastic transformation by constitutively repressing genes. Understanding its mechanism, corepressors, and interaction with EGF-receptor is key to explaining cellular transformation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The v-erbA oncoprotein, a nuclear hormone receptor, is implicated in neoplastic transformation, causing acute erythroleukemia and sarcomas.
  • Its cellular homolog, thyroid hormone receptor alpha (TRalpha), normally regulates gene expression; however, v-ErbA loses the ability to activate genes.
  • v-ErbA is believed to constitutively repress genes that normally prevent cellular transformation, with corepressors playing a role in this silencing mechanism.

Purpose of the Study:

  • To elucidate the mechanisms of cellular transformation induced by the v-erbA oncoprotein.
  • To investigate the role of corepressors in v-erbA-mediated gene silencing.
  • To explore the interplay between v-erbA and the EGF-receptor in cellular transformation.

Main Methods:

Related Experiment Videos

  • The study involves analyzing the function of the v-erbA oncoprotein, a nuclear hormone receptor.
  • Investigating the role of corepressors in gene silencing.
  • Examining the cross-talk between the EGF-receptor and v-ErbA.

Main Results:

  • v-ErbA is a nuclear protein belonging to the nuclear hormone receptor superfamily.
  • v-ErbA oncoprotein is involved in neoplastic transformation.
  • v-ErbA has lost the ability to activate genes and constitutively represses certain genes.

Conclusions:

  • v-ErbA's mechanism of cellular transformation involves constitutive gene repression.
  • Corepressors are crucial in v-erbA-mediated gene silencing.
  • Further research is needed to understand the synergy between v-ErbA and v-ErbB and the EGF-receptor cross-talk.